nodes	percent_of_prediction	percent_of_DWPC	metapath
Dofetilide—CYP3A4—Cytarabine—lymphatic system cancer	0.0865	0.318	CbGbCtD
Dofetilide—CYP3A4—Teniposide—lymphatic system cancer	0.0852	0.313	CbGbCtD
Dofetilide—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0596	0.219	CbGbCtD
Dofetilide—CYP3A4—Vincristine—lymphatic system cancer	0.041	0.151	CbGbCtD
Dofetilide—Sudden death—Teniposide—lymphatic system cancer	0.0313	0.043	CcSEcCtD
Dofetilide—Facial paralysis—Carmustine—lymphatic system cancer	0.0283	0.0389	CcSEcCtD
Dofetilide—Facial paralysis—Vincristine—lymphatic system cancer	0.027	0.0371	CcSEcCtD
Dofetilide—VIIth nerve paralysis—Carmustine—lymphatic system cancer	0.0219	0.0301	CcSEcCtD
Dofetilide—Supraventricular tachycardia—Fludarabine—lymphatic system cancer	0.0215	0.0295	CcSEcCtD
Dofetilide—VIIth nerve paralysis—Vincristine—lymphatic system cancer	0.0209	0.0288	CcSEcCtD
Dofetilide—Sudden death—Mitoxantrone—lymphatic system cancer	0.0163	0.0225	CcSEcCtD
Dofetilide—Paralysis—Vincristine—lymphatic system cancer	0.0124	0.017	CcSEcCtD
Dofetilide—Cardiac failure—Fludarabine—lymphatic system cancer	0.0105	0.0144	CcSEcCtD
Dofetilide—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.0104	0.0143	CcSEcCtD
Dofetilide—Accidental injury—Carmustine—lymphatic system cancer	0.0102	0.014	CcSEcCtD
Dofetilide—Angina pectoris—Fludarabine—lymphatic system cancer	0.00859	0.0118	CcSEcCtD
Dofetilide—Sweating—Teniposide—lymphatic system cancer	0.00858	0.0118	CcSEcCtD
Dofetilide—Sudden death—Methotrexate—lymphatic system cancer	0.00815	0.0112	CcSEcCtD
Dofetilide—Injury—Bleomycin—lymphatic system cancer	0.00814	0.0112	CcSEcCtD
Dofetilide—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00775	0.0107	CcSEcCtD
Dofetilide—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00771	0.0106	CcSEcCtD
Dofetilide—Urinary tract infection—Fludarabine—lymphatic system cancer	0.00765	0.0105	CcSEcCtD
Dofetilide—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00764	0.0105	CcSEcCtD
Dofetilide—Arrhythmia—Teniposide—lymphatic system cancer	0.00718	0.00986	CcSEcCtD
Dofetilide—Injury—Carmustine—lymphatic system cancer	0.00711	0.00977	CcSEcCtD
Dofetilide—Arrhythmia—Fludarabine—lymphatic system cancer	0.00631	0.00867	CcSEcCtD
Dofetilide—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.00622	0.00855	CcSEcCtD
Dofetilide—Hypertension—Teniposide—lymphatic system cancer	0.00604	0.0083	CcSEcCtD
Dofetilide—Paralysis—Methotrexate—lymphatic system cancer	0.006	0.00825	CcSEcCtD
Dofetilide—Chest pain—Teniposide—lymphatic system cancer	0.00595	0.00818	CcSEcCtD
Dofetilide—Cardiac arrest—Vincristine—lymphatic system cancer	0.00593	0.00815	CcSEcCtD
Dofetilide—Oedema—Teniposide—lymphatic system cancer	0.00571	0.00785	CcSEcCtD
Dofetilide—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00569	0.00781	CcSEcCtD
Dofetilide—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00565	0.00777	CcSEcCtD
Dofetilide—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00552	0.00758	CcSEcCtD
Dofetilide—Cough—Fludarabine—lymphatic system cancer	0.00536	0.00737	CcSEcCtD
Dofetilide—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0053	0.00728	CcSEcCtD
Dofetilide—Arthralgia—Fludarabine—lymphatic system cancer	0.00523	0.00719	CcSEcCtD
Dofetilide—Dyspnoea—Teniposide—lymphatic system cancer	0.00509	0.00699	CcSEcCtD
Dofetilide—Oedema—Fludarabine—lymphatic system cancer	0.00502	0.00689	CcSEcCtD
Dofetilide—Urinary tract infection—Carmustine—lymphatic system cancer	0.00489	0.00673	CcSEcCtD
Dofetilide—Rash—Mechlorethamine—lymphatic system cancer	0.00488	0.00671	CcSEcCtD
Dofetilide—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00488	0.0067	CcSEcCtD
Dofetilide—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00485	0.00667	CcSEcCtD
Dofetilide—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00474	0.00651	CcSEcCtD
Dofetilide—Myocardial infarction—Vincristine—lymphatic system cancer	0.00471	0.00647	CcSEcCtD
Dofetilide—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00467	0.00642	CcSEcCtD
Dofetilide—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00461	0.00634	CcSEcCtD
Dofetilide—Sweating—Vincristine—lymphatic system cancer	0.00461	0.00633	CcSEcCtD
Dofetilide—Nausea—Mechlorethamine—lymphatic system cancer	0.0046	0.00632	CcSEcCtD
Dofetilide—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00459	0.00631	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00457	0.00628	CcSEcCtD
Dofetilide—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00455	0.00625	CcSEcCtD
Dofetilide—Abdominal pain—Teniposide—lymphatic system cancer	0.00451	0.0062	CcSEcCtD
Dofetilide—Paraesthesia—Fludarabine—lymphatic system cancer	0.0045	0.00619	CcSEcCtD
Dofetilide—Sweating—Mitoxantrone—lymphatic system cancer	0.00449	0.00617	CcSEcCtD
Dofetilide—Dyspnoea—Fludarabine—lymphatic system cancer	0.00447	0.00615	CcSEcCtD
Dofetilide—Oedema peripheral—Carmustine—lymphatic system cancer	0.00445	0.00612	CcSEcCtD
Dofetilide—Pain—Fludarabine—lymphatic system cancer	0.00429	0.0059	CcSEcCtD
Dofetilide—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00428	0.00588	CcSEcCtD
Dofetilide—Asthenia—Teniposide—lymphatic system cancer	0.0041	0.00563	CcSEcCtD
Dofetilide—Arrhythmia—Carmustine—lymphatic system cancer	0.00404	0.00555	CcSEcCtD
Dofetilide—Cough—Bleomycin—lymphatic system cancer	0.00393	0.00541	CcSEcCtD
Dofetilide—Diarrhoea—Teniposide—lymphatic system cancer	0.00391	0.00537	CcSEcCtD
Dofetilide—Chest pain—Bleomycin—lymphatic system cancer	0.00384	0.00527	CcSEcCtD
Dofetilide—Back pain—Carmustine—lymphatic system cancer	0.00381	0.00523	CcSEcCtD
Dofetilide—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00375	0.00516	CcSEcCtD
Dofetilide—Oedema—Bleomycin—lymphatic system cancer	0.00368	0.00506	CcSEcCtD
Dofetilide—Back pain—Vincristine—lymphatic system cancer	0.00363	0.00499	CcSEcCtD
Dofetilide—Asthenia—Fludarabine—lymphatic system cancer	0.0036	0.00495	CcSEcCtD
Dofetilide—Rash—Teniposide—lymphatic system cancer	0.0036	0.00495	CcSEcCtD
Dofetilide—Dermatitis—Teniposide—lymphatic system cancer	0.0036	0.00494	CcSEcCtD
Dofetilide—Headache—Teniposide—lymphatic system cancer	0.00358	0.00491	CcSEcCtD
Dofetilide—Back pain—Mitoxantrone—lymphatic system cancer	0.00354	0.00486	CcSEcCtD
Dofetilide—Diarrhoea—Fludarabine—lymphatic system cancer	0.00343	0.00472	CcSEcCtD
Dofetilide—Hypertension—Carmustine—lymphatic system cancer	0.0034	0.00467	CcSEcCtD
Dofetilide—Nausea—Teniposide—lymphatic system cancer	0.00339	0.00466	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00335	0.00461	CcSEcCtD
Dofetilide—Chest pain—Carmustine—lymphatic system cancer	0.00335	0.0046	CcSEcCtD
Dofetilide—Anxiety—Carmustine—lymphatic system cancer	0.00334	0.00459	CcSEcCtD
Dofetilide—Paraesthesia—Bleomycin—lymphatic system cancer	0.0033	0.00454	CcSEcCtD
Dofetilide—Dyspnoea—Bleomycin—lymphatic system cancer	0.00328	0.00451	CcSEcCtD
Dofetilide—Hypertension—Vincristine—lymphatic system cancer	0.00324	0.00446	CcSEcCtD
Dofetilide—Oedema—Carmustine—lymphatic system cancer	0.00321	0.00441	CcSEcCtD
Dofetilide—Cough—Mitoxantrone—lymphatic system cancer	0.00319	0.00439	CcSEcCtD
Dofetilide—Rash—Fludarabine—lymphatic system cancer	0.00316	0.00435	CcSEcCtD
Dofetilide—Dermatitis—Fludarabine—lymphatic system cancer	0.00316	0.00434	CcSEcCtD
Dofetilide—Hypertension—Mitoxantrone—lymphatic system cancer	0.00316	0.00434	CcSEcCtD
Dofetilide—Pain—Bleomycin—lymphatic system cancer	0.00315	0.00432	CcSEcCtD
Dofetilide—Headache—Fludarabine—lymphatic system cancer	0.00314	0.00432	CcSEcCtD
Dofetilide—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00311	0.00428	CcSEcCtD
Dofetilide—Chest pain—Mitoxantrone—lymphatic system cancer	0.00311	0.00428	CcSEcCtD
Dofetilide—Anxiety—Mitoxantrone—lymphatic system cancer	0.0031	0.00426	CcSEcCtD
Dofetilide—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00309	0.00424	CcSEcCtD
Dofetilide—Oedema—Vincristine—lymphatic system cancer	0.00307	0.00421	CcSEcCtD
Dofetilide—Oedema—Mitoxantrone—lymphatic system cancer	0.00299	0.0041	CcSEcCtD
Dofetilide—Nausea—Fludarabine—lymphatic system cancer	0.00298	0.0041	CcSEcCtD
Dofetilide—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00296	0.00407	CcSEcCtD
Dofetilide—Shock—Mitoxantrone—lymphatic system cancer	0.00294	0.00404	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00293	0.00402	CcSEcCtD
Dofetilide—Insomnia—Carmustine—lymphatic system cancer	0.0029	0.00399	CcSEcCtD
Dofetilide—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00289	0.00397	CcSEcCtD
Dofetilide—Paraesthesia—Carmustine—lymphatic system cancer	0.00288	0.00396	CcSEcCtD
Dofetilide—Dyspnoea—Carmustine—lymphatic system cancer	0.00286	0.00393	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00279	0.00384	CcSEcCtD
Dofetilide—Insomnia—Vincristine—lymphatic system cancer	0.00277	0.00381	CcSEcCtD
Dofetilide—Paraesthesia—Vincristine—lymphatic system cancer	0.00275	0.00378	CcSEcCtD
Dofetilide—Pain—Carmustine—lymphatic system cancer	0.00275	0.00377	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00272	0.00374	CcSEcCtD
Dofetilide—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00268	0.00368	CcSEcCtD
Dofetilide—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00266	0.00366	CcSEcCtD
Dofetilide—Asthenia—Bleomycin—lymphatic system cancer	0.00264	0.00363	CcSEcCtD
Dofetilide—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00263	0.00361	CcSEcCtD
Dofetilide—Pain—Vincristine—lymphatic system cancer	0.00262	0.0036	CcSEcCtD
Dofetilide—Pain—Mitoxantrone—lymphatic system cancer	0.00255	0.00351	CcSEcCtD
Dofetilide—Abdominal pain—Carmustine—lymphatic system cancer	0.00254	0.00349	CcSEcCtD
Dofetilide—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00251	0.00344	CcSEcCtD
Dofetilide—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00244	0.00335	CcSEcCtD
Dofetilide—Abdominal pain—Vincristine—lymphatic system cancer	0.00242	0.00333	CcSEcCtD
Dofetilide—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00236	0.00324	CcSEcCtD
Dofetilide—Rash—Bleomycin—lymphatic system cancer	0.00232	0.00319	CcSEcCtD
Dofetilide—Dermatitis—Bleomycin—lymphatic system cancer	0.00232	0.00318	CcSEcCtD
Dofetilide—Asthenia—Carmustine—lymphatic system cancer	0.0023	0.00317	CcSEcCtD
Dofetilide—Sweating—Methotrexate—lymphatic system cancer	0.00224	0.00307	CcSEcCtD
Dofetilide—Asthenia—Vincristine—lymphatic system cancer	0.0022	0.00302	CcSEcCtD
Dofetilide—Diarrhoea—Carmustine—lymphatic system cancer	0.0022	0.00302	CcSEcCtD
Dofetilide—Nausea—Bleomycin—lymphatic system cancer	0.00218	0.003	CcSEcCtD
Dofetilide—Asthenia—Mitoxantrone—lymphatic system cancer	0.00214	0.00294	CcSEcCtD
Dofetilide—Dizziness—Carmustine—lymphatic system cancer	0.00212	0.00292	CcSEcCtD
Dofetilide—Diarrhoea—Vincristine—lymphatic system cancer	0.0021	0.00288	CcSEcCtD
Dofetilide—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00204	0.00281	CcSEcCtD
Dofetilide—Dizziness—Vincristine—lymphatic system cancer	0.00203	0.00279	CcSEcCtD
Dofetilide—Rash—Carmustine—lymphatic system cancer	0.00202	0.00278	CcSEcCtD
Dofetilide—Dermatitis—Carmustine—lymphatic system cancer	0.00202	0.00278	CcSEcCtD
Dofetilide—Headache—Carmustine—lymphatic system cancer	0.00201	0.00276	CcSEcCtD
Dofetilide—Rash—Vincristine—lymphatic system cancer	0.00193	0.00266	CcSEcCtD
Dofetilide—Dermatitis—Vincristine—lymphatic system cancer	0.00193	0.00265	CcSEcCtD
Dofetilide—Headache—Vincristine—lymphatic system cancer	0.00192	0.00264	CcSEcCtD
Dofetilide—Nausea—Carmustine—lymphatic system cancer	0.00191	0.00262	CcSEcCtD
Dofetilide—Rash—Mitoxantrone—lymphatic system cancer	0.00188	0.00259	CcSEcCtD
Dofetilide—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00188	0.00258	CcSEcCtD
Dofetilide—Headache—Mitoxantrone—lymphatic system cancer	0.00187	0.00257	CcSEcCtD
Dofetilide—Nausea—Vincristine—lymphatic system cancer	0.00182	0.0025	CcSEcCtD
Dofetilide—Nausea—Mitoxantrone—lymphatic system cancer	0.00177	0.00244	CcSEcCtD
Dofetilide—Back pain—Methotrexate—lymphatic system cancer	0.00176	0.00242	CcSEcCtD
Dofetilide—Cough—Methotrexate—lymphatic system cancer	0.00159	0.00219	CcSEcCtD
Dofetilide—Chest pain—Methotrexate—lymphatic system cancer	0.00155	0.00213	CcSEcCtD
Dofetilide—Arthralgia—Methotrexate—lymphatic system cancer	0.00155	0.00213	CcSEcCtD
Dofetilide—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00144	0.00198	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00135	0.00186	CcSEcCtD
Dofetilide—Insomnia—Methotrexate—lymphatic system cancer	0.00135	0.00185	CcSEcCtD
Dofetilide—Paraesthesia—Methotrexate—lymphatic system cancer	0.00134	0.00184	CcSEcCtD
Dofetilide—Dyspnoea—Methotrexate—lymphatic system cancer	0.00133	0.00182	CcSEcCtD
Dofetilide—Pain—Methotrexate—lymphatic system cancer	0.00127	0.00175	CcSEcCtD
Dofetilide—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00122	0.00167	CcSEcCtD
Dofetilide—Abdominal pain—Methotrexate—lymphatic system cancer	0.00118	0.00162	CcSEcCtD
Dofetilide—Asthenia—Methotrexate—lymphatic system cancer	0.00107	0.00147	CcSEcCtD
Dofetilide—Diarrhoea—Methotrexate—lymphatic system cancer	0.00102	0.0014	CcSEcCtD
Dofetilide—Dizziness—Methotrexate—lymphatic system cancer	0.000983	0.00135	CcSEcCtD
Dofetilide—Rash—Methotrexate—lymphatic system cancer	0.000938	0.00129	CcSEcCtD
Dofetilide—Dermatitis—Methotrexate—lymphatic system cancer	0.000937	0.00129	CcSEcCtD
Dofetilide—Headache—Methotrexate—lymphatic system cancer	0.000932	0.00128	CcSEcCtD
Dofetilide—Nausea—Methotrexate—lymphatic system cancer	0.000883	0.00121	CcSEcCtD
